The impact of factor XIII on coagulation kinetics and clot strength determined by thrombelastogrhy

Vance G Nielsen, William Q. Gurley, Thomas M. Burch

Research output: Contribution to journalArticle

97 Citations (Scopus)

Abstract

Fibrinogen has been shown to be responsible for most protein-mediated clot strength via thrombelastography. However, factor XIII (FXIII) activity also plays a prominent role in the development of clot strength. Thus, we hypothesized that changes in FXIII activity would significantly increase clot strength. FXIII (0%, 1%, 6.25%, 12.5%, 25%, 50%, and 100% normal activity) was placed in a fixed volume of citrated FXIII-deficient plasma with 1% tissue factor and calcium chloride and underwent thrombelastography for 10 min. We measured the variables reaction time (R; a measurement of clot initiation), α (a measure of the rate of clot formation), amplitude (A; a measure of clot strength), and shear elastic modulus (G; a measure of clot strength). FXIII activity significantly decreased R in a pattern of exponential decay (R 2 = 0.77; P < 0.001). FXIII activity significantly increased α, following a sigmoidal pattern (R2 = 0.88; P < 0.001). Finally, increases in FXIII activity significantly increased A and G in a sigmoidal pattern (R2 = 0.89; P < 0.001). We concluded that FXIII significantly affects R, alpha, A, and G. Thus, transfusion decision making with protein-mediated thrombelastographic patterns must account for the contribution of both fibrinogen and FXIII.

Original languageEnglish (US)
Pages (from-to)120-123
Number of pages4
JournalAnesthesia and Analgesia
Volume99
Issue number1
StatePublished - Jul 2004
Externally publishedYes

Fingerprint

Factor XIII
Thrombelastography
Fibrinogen
Shear Strength
Calcium Chloride
Elastic Modulus
Thromboplastin
Decision Making
Proteins

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

The impact of factor XIII on coagulation kinetics and clot strength determined by thrombelastogrhy. / Nielsen, Vance G; Gurley, William Q.; Burch, Thomas M.

In: Anesthesia and Analgesia, Vol. 99, No. 1, 07.2004, p. 120-123.

Research output: Contribution to journalArticle

@article{05b94ec4e9884c47a201598e24c43b29,
title = "The impact of factor XIII on coagulation kinetics and clot strength determined by thrombelastogrhy",
abstract = "Fibrinogen has been shown to be responsible for most protein-mediated clot strength via thrombelastography. However, factor XIII (FXIII) activity also plays a prominent role in the development of clot strength. Thus, we hypothesized that changes in FXIII activity would significantly increase clot strength. FXIII (0{\%}, 1{\%}, 6.25{\%}, 12.5{\%}, 25{\%}, 50{\%}, and 100{\%} normal activity) was placed in a fixed volume of citrated FXIII-deficient plasma with 1{\%} tissue factor and calcium chloride and underwent thrombelastography for 10 min. We measured the variables reaction time (R; a measurement of clot initiation), α (a measure of the rate of clot formation), amplitude (A; a measure of clot strength), and shear elastic modulus (G; a measure of clot strength). FXIII activity significantly decreased R in a pattern of exponential decay (R 2 = 0.77; P < 0.001). FXIII activity significantly increased α, following a sigmoidal pattern (R2 = 0.88; P < 0.001). Finally, increases in FXIII activity significantly increased A and G in a sigmoidal pattern (R2 = 0.89; P < 0.001). We concluded that FXIII significantly affects R, alpha, A, and G. Thus, transfusion decision making with protein-mediated thrombelastographic patterns must account for the contribution of both fibrinogen and FXIII.",
author = "Nielsen, {Vance G} and Gurley, {William Q.} and Burch, {Thomas M.}",
year = "2004",
month = "7",
language = "English (US)",
volume = "99",
pages = "120--123",
journal = "Anesthesia and Analgesia",
issn = "0003-2999",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - The impact of factor XIII on coagulation kinetics and clot strength determined by thrombelastogrhy

AU - Nielsen, Vance G

AU - Gurley, William Q.

AU - Burch, Thomas M.

PY - 2004/7

Y1 - 2004/7

N2 - Fibrinogen has been shown to be responsible for most protein-mediated clot strength via thrombelastography. However, factor XIII (FXIII) activity also plays a prominent role in the development of clot strength. Thus, we hypothesized that changes in FXIII activity would significantly increase clot strength. FXIII (0%, 1%, 6.25%, 12.5%, 25%, 50%, and 100% normal activity) was placed in a fixed volume of citrated FXIII-deficient plasma with 1% tissue factor and calcium chloride and underwent thrombelastography for 10 min. We measured the variables reaction time (R; a measurement of clot initiation), α (a measure of the rate of clot formation), amplitude (A; a measure of clot strength), and shear elastic modulus (G; a measure of clot strength). FXIII activity significantly decreased R in a pattern of exponential decay (R 2 = 0.77; P < 0.001). FXIII activity significantly increased α, following a sigmoidal pattern (R2 = 0.88; P < 0.001). Finally, increases in FXIII activity significantly increased A and G in a sigmoidal pattern (R2 = 0.89; P < 0.001). We concluded that FXIII significantly affects R, alpha, A, and G. Thus, transfusion decision making with protein-mediated thrombelastographic patterns must account for the contribution of both fibrinogen and FXIII.

AB - Fibrinogen has been shown to be responsible for most protein-mediated clot strength via thrombelastography. However, factor XIII (FXIII) activity also plays a prominent role in the development of clot strength. Thus, we hypothesized that changes in FXIII activity would significantly increase clot strength. FXIII (0%, 1%, 6.25%, 12.5%, 25%, 50%, and 100% normal activity) was placed in a fixed volume of citrated FXIII-deficient plasma with 1% tissue factor and calcium chloride and underwent thrombelastography for 10 min. We measured the variables reaction time (R; a measurement of clot initiation), α (a measure of the rate of clot formation), amplitude (A; a measure of clot strength), and shear elastic modulus (G; a measure of clot strength). FXIII activity significantly decreased R in a pattern of exponential decay (R 2 = 0.77; P < 0.001). FXIII activity significantly increased α, following a sigmoidal pattern (R2 = 0.88; P < 0.001). Finally, increases in FXIII activity significantly increased A and G in a sigmoidal pattern (R2 = 0.89; P < 0.001). We concluded that FXIII significantly affects R, alpha, A, and G. Thus, transfusion decision making with protein-mediated thrombelastographic patterns must account for the contribution of both fibrinogen and FXIII.

UR - http://www.scopus.com/inward/record.url?scp=3042662496&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3042662496&partnerID=8YFLogxK

M3 - Article

C2 - 15281516

AN - SCOPUS:3042662496

VL - 99

SP - 120

EP - 123

JO - Anesthesia and Analgesia

JF - Anesthesia and Analgesia

SN - 0003-2999

IS - 1

ER -